CA3056919A1 - Methode de traitement d'affections cutanees des paupieres - Google Patents
Methode de traitement d'affections cutanees des paupieres Download PDFInfo
- Publication number
- CA3056919A1 CA3056919A1 CA3056919A CA3056919A CA3056919A1 CA 3056919 A1 CA3056919 A1 CA 3056919A1 CA 3056919 A CA3056919 A CA 3056919A CA 3056919 A CA3056919 A CA 3056919A CA 3056919 A1 CA3056919 A1 CA 3056919A1
- Authority
- CA
- Canada
- Prior art keywords
- skin
- patient
- treatment
- eye lids
- tenting
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
- 238000000034 method Methods 0.000 title claims abstract description 32
- 210000000744 eyelid Anatomy 0.000 title claims abstract description 20
- 238000011282 treatment Methods 0.000 title claims description 23
- 210000003491 skin Anatomy 0.000 claims description 34
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 claims description 28
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 claims description 15
- 239000000203 mixture Substances 0.000 claims description 15
- 238000002347 injection Methods 0.000 claims description 13
- 239000007924 injection Substances 0.000 claims description 13
- 239000000243 solution Substances 0.000 claims description 11
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 10
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 claims description 9
- 210000000577 adipose tissue Anatomy 0.000 claims description 6
- 239000001509 sodium citrate Substances 0.000 claims description 6
- NLJMYIDDQXHKNR-UHFFFAOYSA-K sodium citrate Chemical compound O.O.[Na+].[Na+].[Na+].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O NLJMYIDDQXHKNR-UHFFFAOYSA-K 0.000 claims description 6
- 102000004169 proteins and genes Human genes 0.000 claims description 5
- 108090000623 proteins and genes Proteins 0.000 claims description 5
- 150000003839 salts Chemical class 0.000 claims description 5
- 239000011780 sodium chloride Substances 0.000 claims description 5
- 206010015995 Eyelid ptosis Diseases 0.000 claims description 4
- 239000000872 buffer Substances 0.000 claims description 4
- 239000002537 cosmetic Substances 0.000 claims description 4
- 239000003792 electrolyte Substances 0.000 claims description 4
- 201000003004 ptosis Diseases 0.000 claims description 4
- 238000001990 intravenous administration Methods 0.000 claims description 3
- 239000000843 powder Substances 0.000 claims description 3
- 230000037303 wrinkles Effects 0.000 claims description 3
- 208000002352 blister Diseases 0.000 claims description 2
- 210000002808 connective tissue Anatomy 0.000 claims description 2
- 230000008602 contraction Effects 0.000 claims description 2
- 230000006735 deficit Effects 0.000 claims description 2
- 210000004207 dermis Anatomy 0.000 claims description 2
- 230000001815 facial effect Effects 0.000 claims description 2
- 230000007935 neutral effect Effects 0.000 claims description 2
- 206010033675 panniculitis Diseases 0.000 claims description 2
- 239000011148 porous material Substances 0.000 claims description 2
- 238000005728 strengthening Methods 0.000 claims description 2
- 210000004003 subcutaneous fat Anatomy 0.000 claims description 2
- 238000010254 subcutaneous injection Methods 0.000 claims description 2
- 239000007929 subcutaneous injection Substances 0.000 claims description 2
- 210000004304 subcutaneous tissue Anatomy 0.000 claims description 2
- 238000001356 surgical procedure Methods 0.000 claims description 2
- 239000008151 electrolyte solution Substances 0.000 claims 1
- 230000003449 preventive effect Effects 0.000 claims 1
- 201000004569 Blindness Diseases 0.000 description 3
- 230000032683 aging Effects 0.000 description 3
- 210000001519 tissue Anatomy 0.000 description 3
- KRKNYBCHXYNGOX-UHFFFAOYSA-K Citrate Chemical compound [O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O KRKNYBCHXYNGOX-UHFFFAOYSA-K 0.000 description 2
- 239000007864 aqueous solution Substances 0.000 description 2
- 230000002950 deficient Effects 0.000 description 2
- 230000000694 effects Effects 0.000 description 2
- 238000009472 formulation Methods 0.000 description 2
- 238000002360 preparation method Methods 0.000 description 2
- 239000008223 sterile water Substances 0.000 description 2
- 238000007920 subcutaneous administration Methods 0.000 description 2
- 241000299354 Acalles micros Species 0.000 description 1
- 206010002091 Anaesthesia Diseases 0.000 description 1
- 241000543381 Cliftonia monophylla Species 0.000 description 1
- 208000034656 Contusions Diseases 0.000 description 1
- 102000016942 Elastin Human genes 0.000 description 1
- 108010014258 Elastin Proteins 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- 208000032843 Hemorrhage Diseases 0.000 description 1
- 206010047571 Visual impairment Diseases 0.000 description 1
- 239000004480 active ingredient Substances 0.000 description 1
- 230000037005 anaesthesia Effects 0.000 description 1
- 230000003796 beauty Effects 0.000 description 1
- 208000034158 bleeding Diseases 0.000 description 1
- 230000000740 bleeding effect Effects 0.000 description 1
- 238000009534 blood test Methods 0.000 description 1
- 238000012937 correction Methods 0.000 description 1
- 239000006071 cream Substances 0.000 description 1
- 201000010251 cutis laxa Diseases 0.000 description 1
- 230000007812 deficiency Effects 0.000 description 1
- 230000003111 delayed effect Effects 0.000 description 1
- 239000008121 dextrose Substances 0.000 description 1
- 230000002500 effect on skin Effects 0.000 description 1
- 229920002549 elastin Polymers 0.000 description 1
- 210000002615 epidermis Anatomy 0.000 description 1
- 238000001914 filtration Methods 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 208000015181 infectious disease Diseases 0.000 description 1
- 230000028709 inflammatory response Effects 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 238000011221 initial treatment Methods 0.000 description 1
- 238000011283 initial treatment period Methods 0.000 description 1
- 230000001678 irradiating effect Effects 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 210000003205 muscle Anatomy 0.000 description 1
- FFNMBRCFFADNAO-UHFFFAOYSA-N pirenzepine hydrochloride Chemical compound [H+].[H+].[Cl-].[Cl-].C1CN(C)CCN1CC(=O)N1C2=NC=CC=C2NC(=O)C2=CC=CC=C21 FFNMBRCFFADNAO-UHFFFAOYSA-N 0.000 description 1
- 230000009103 reabsorption Effects 0.000 description 1
- 238000012827 research and development Methods 0.000 description 1
- 230000004044 response Effects 0.000 description 1
- 230000037390 scarring Effects 0.000 description 1
- 210000002966 serum Anatomy 0.000 description 1
- 239000008247 solid mixture Substances 0.000 description 1
- 239000003206 sterilizing agent Substances 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 230000008685 targeting Effects 0.000 description 1
- 230000002123 temporal effect Effects 0.000 description 1
- 208000029257 vision disease Diseases 0.000 description 1
- 230000004393 visual impairment Effects 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/005—Preparations for sensitive skin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/34—Alcohols
- A61K8/345—Alcohols containing more than one hydroxy group
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/36—Carboxylic acids; Salts or anhydrides thereof
- A61K8/365—Hydroxycarboxylic acids; Ketocarboxylic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/80—Process related aspects concerning the preparation of the cosmetic composition or the storage or application thereof
- A61K2800/88—Two- or multipart kits
- A61K2800/882—Mixing prior to application
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/80—Process related aspects concerning the preparation of the cosmetic composition or the storage or application thereof
- A61K2800/91—Injection
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Emergency Medicine (AREA)
- Birds (AREA)
- Epidemiology (AREA)
- Dermatology (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicinal Preparation (AREA)
- Percussion Or Vibration Massage (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Abstract
L'invention concerne une méthode destinée au resserrement sur l'hypoderme de cloisons de graisse et de réduction du plissage de la peau, du retard de la peau et du surplomb de la peau sur les paupières supérieures et inférieures.
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| PCT/US2017/024201 WO2018182562A1 (fr) | 2017-03-26 | 2017-03-26 | Méthode de traitement d'affections cutanées des paupières |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CA3056919A1 true CA3056919A1 (fr) | 2018-10-04 |
Family
ID=63678310
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CA3056919A Abandoned CA3056919A1 (fr) | 2017-03-26 | 2017-03-26 | Methode de traitement d'affections cutanees des paupieres |
Country Status (5)
| Country | Link |
|---|---|
| EP (1) | EP3600233A4 (fr) |
| CN (1) | CN110582264B (fr) |
| CA (1) | CA3056919A1 (fr) |
| MX (1) | MX2019011603A (fr) |
| WO (1) | WO2018182562A1 (fr) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20200016056A1 (en) * | 2018-01-05 | 2020-01-16 | Vivi Robyn Stafford | Method of subcutaneous aqueous citric acid injection non-surgical skin tightening excluding orbit |
Family Cites Families (19)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB815517A (en) * | 1955-06-20 | 1959-06-24 | Upjohn Co | Dihydro novobiocin, its salts and other derivatives and pharmaceutical compositions containing same |
| WO1989007945A1 (fr) * | 1988-02-26 | 1989-09-08 | Genentech, Inc. | Formulation de relaxine humaine |
| CA2153553A1 (fr) * | 1994-07-13 | 1996-01-14 | Hidekazu Suzuki | Emulsion stable de lipides |
| CA2552442A1 (fr) * | 2002-12-31 | 2004-06-30 | Avon Products, Inc. | Compositions et procede d'administration pour le traitement de rides, fins sillons et de l'hyperhidrose |
| JP2004292400A (ja) * | 2003-03-28 | 2004-10-21 | Ichimaru Pharcos Co Ltd | メイラード反応阻害剤及び化粧料組成物又は食品 |
| CA2846382C (fr) * | 2004-02-20 | 2017-09-19 | The Hospital For Sick Children | Composes a base de manganese destines a l'elastogenese et au traitement de tissu connectif |
| US7754230B2 (en) * | 2004-05-19 | 2010-07-13 | The Regents Of The University Of California | Methods and related compositions for reduction of fat |
| US20060127468A1 (en) * | 2004-05-19 | 2006-06-15 | Kolodney Michael S | Methods and related compositions for reduction of fat and skin tightening |
| RU2006146555A (ru) * | 2004-05-28 | 2008-07-20 | Шеринг Копрорейшн (Us) | Инъецируемые фармацевтические композиции позаконазола со стабилизированными частицами |
| US20070298005A1 (en) * | 2006-06-22 | 2007-12-27 | Marie-Josee Thibault | Injectable composition for treatment of skin defects or deformations |
| AR083847A1 (es) * | 2010-11-15 | 2013-03-27 | Novartis Ag | Variantes de fc (fragmento constante) silenciosas de los anticuerpos anti-cd40 |
| US20130052244A1 (en) * | 2011-08-30 | 2013-02-28 | Mark Weinreb | Stem Cell Compositions and Methods |
| EP2771033A4 (fr) * | 2011-10-28 | 2016-02-17 | Integritybio Inc | Formulations protéiques contenant des acides aminés |
| RU2512801C1 (ru) * | 2012-10-08 | 2014-04-10 | Ирина Юрьевна Юхман | Лечебно-профилактический бальзам для глаз |
| WO2014201618A1 (fr) * | 2013-06-18 | 2014-12-24 | 山东省生物药物研究院 | Utilisation de gomme de xanthane dans la préparation de produits de beauté injectables |
| AR102869A1 (es) * | 2014-12-16 | 2017-03-29 | Lilly Co Eli | Composiciones de insulina de rápida acción |
| TWI773641B (zh) * | 2015-05-08 | 2022-08-11 | 日商活效製藥股份有限公司 | 含有糖皮質類固醇（ｇｌｕｃｏｃｏｒｔｉｃｏｉｄｓ）之奈米微粒子之水性懸浮液劑 |
| US9744110B2 (en) * | 2015-09-29 | 2017-08-29 | Debra Louise Stafford | Method of treating conditions of the eyelid |
| US20180078621A1 (en) * | 2016-09-22 | 2018-03-22 | Kyoung Lack Lee | Composition for hypotonic lipolysis and manufacturing method thereof |
-
2017
- 2017-03-26 CA CA3056919A patent/CA3056919A1/fr not_active Abandoned
- 2017-03-26 WO PCT/US2017/024201 patent/WO2018182562A1/fr unknown
- 2017-03-26 MX MX2019011603A patent/MX2019011603A/es unknown
- 2017-03-26 EP EP17902778.4A patent/EP3600233A4/fr not_active Withdrawn
- 2017-03-26 CN CN201780090412.0A patent/CN110582264B/zh active Active
Also Published As
| Publication number | Publication date |
|---|---|
| EP3600233A1 (fr) | 2020-02-05 |
| MX2019011603A (es) | 2021-08-16 |
| CN110582264B (zh) | 2022-11-11 |
| EP3600233A4 (fr) | 2020-10-21 |
| CN110582264A (zh) | 2019-12-17 |
| WO2018182562A1 (fr) | 2018-10-04 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| RU2690845C2 (ru) | Способ для стимулирования роста волос и предотвращения выпадения волос пациента, вещество для него и способ получения вещества | |
| CN101554369B (zh) | 一种外用复合油纳米乳喷雾剂和滴眼剂及其制备方法 | |
| Tran et al. | Vision loss and blindness following fillers | |
| Beatini et al. | Hyaluronic acid hybrid cooperative complexes and the BAP (Bio Aesthetic Points) technique: the new edge in biorejuvenation | |
| CA3056919A1 (fr) | Methode de traitement d'affections cutanees des paupieres | |
| US9744110B2 (en) | Method of treating conditions of the eyelid | |
| RU2703531C1 (ru) | Способ коррекции устойчивых дефектов кожи | |
| Allen et al. | Intravenous procaine analgesia | |
| WO2015126942A1 (fr) | Compositions et méthodes destinées à atténuer la douleur sans engourdir | |
| Hotta | Lip enhancement: physical assessment, injection techniques, and potential adverse events | |
| Akoglu et al. | A case report of episcleral artery embolism caused by hyaluronic acid injection into the malar area. | |
| RU2817931C1 (ru) | Способ омоложения тканей лица и шеи у пациентов с признаками гипертонуса мышц-депрессоров, вызывающими старение | |
| Yanes et al. | Poly-L-Lactic Acid | |
| Braccini | New trends in rhinoplasty. | |
| KR102629903B1 (ko) | N-아세틸글루코사민 유도체를 유효성분으로 함유하는 주입용 필러 조성물 | |
| RU2666942C1 (ru) | Способ лечения полинейромиопатии критических состояний у реанимационных больных | |
| RU2659959C1 (ru) | Состав препарата для коррекции дефектов кожи | |
| RU2393823C1 (ru) | Устройство для локальной доставки лекарственных растворов, применяемых в офтальмологии | |
| RU2648181C1 (ru) | Способ лечения нейроретинопатии вследствие тяжелой преэклампсии | |
| RU2498826C1 (ru) | Способ лечения больных с черепно-мозговой травмой | |
| US20200016056A1 (en) | Method of subcutaneous aqueous citric acid injection non-surgical skin tightening excluding orbit | |
| Velthuis et al. | Fillers and Vessels: The Story of Arterial Obstruction after Cosmetic Treatment. J Angiol Vasc Surg 6: 069 | |
| Braccini | Medical rhinoplasty | |
| RU2625654C1 (ru) | Способ местного консервативного лечения миопии | |
| Vu et al. | HYALURONIC ACID FILLER INJECTION FOR COSMETIC PURPOSE: SKIN NECROSIS COMPLICATION AND TREATMENT-CASES REPORTS |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FZDE | Discontinued |
Effective date: 20220927 |
|
| FZDE | Discontinued |
Effective date: 20220927 |